Seres Therapeutics Inc.

05/22/2022 | Press release | Distributed by Public on 05/22/2022 13:22

Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.